Senior Accounts Payable Specialist
- Employer
- Sutro Biopharma, Inc
- Location
- South San Francisco, CA
- Salary
- $90,000 to 115,000
- Start date
- Oct 17, 2024
View more categoriesView less categories
- Discipline
- Administration, Accounting, Clinical
- Required Education
- Bachelors Degree
- Position Type
- Full time
- Hotbed
- Biotech Bay, Best Places to Work
Job Details
- Invoice Processing: Review, verify, and process a high volume of invoices in accordance with company policies and procedures.
- Vendor Management: Build and maintain positive relationships with vendors, addressing discrepancies and inquiries regarding invoices and payments.
- Payment Processing: Prepare and execute payment runs, including checks and electronic transfers, ensuring timely and accurate disbursements.
- Reconciliations: Conduct regular account reconciliations, resolve discrepancies, and assist with month-end closing activities.
- Process Improvement: Identify and implement enhancements to streamline the accounts payable workflow and improve overall efficiency.
- Compliance: Ensure compliance with internal controls and regulatory requirements related to accounts payable.
- Bachelor’s degree in accounting, Finance, or a related field preferred.
- 5+ years of accounts payable experience, with a strong understanding of AP processes.
- Proficiency in accounting software and ERP systems (e.g., D365, Oracle, QuickBooks).
- Strong analytical and problem-solving skills.
- Excellent communication and interpersonal skills.
- High attention to detail and accuracy.
- Ability to work independently and collaboratively in a fast-paced environment.
- Knowledge of D365 Finance and Operations or similar ERP system is a plus.
Company
Sutro Biopharma, Inc., is a clinical-stage company relentlessly focused on the discovery and development of precisely designed cancer therapeutics, transforming what science can do for patients. Sutro’s fit-for-purpose technology, including cell-free XpressCF®, provides the opportunity for broader patient benefit and an improved patient experience. Sutro has multiple clinical stage candidates, including luveltamab tazevibulin, or luvelta, a registrational-stage folate receptor alpha (FolRα)-targeting ADC in clinical studies. A robust pipeline, coupled with high-value collaborations and industry partnerships, validates our continuous product innovation. Sutro is headquartered in South San Francisco. For more information, follow Sutro on social media @Sutrobio, or visit www.sutrobio.com.
Stock Symbol: STRO
Bill Newell, CEO Interviewed by Brad Loncar, Founder, Biotech TV – “Sutro Biopharma’s CEO on ADCs, non-cell protein synthesis, and more" - view it here
- Website
- http://www.sutrobio.com/
- Phone
- 650.881.6500
- Location
-
111 Oyster Point Blvd
South San Francisco
California
94080
US
Get job alerts
Create a job alert and receive personalized job recommendations straight to your inbox.
Create alert